EGFR and T-cell non-Hodgkin lymphoma: Examples include TP53 point mutations or EGFR copy number variations across multiple cancer types [37, 38], or POT1 depletion, a particularly aggressive alteration that is suggested to dramatically accelerate tumorigenesis in T cell lymphoma [39].